See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Chemical Class · Lipids
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62245 |
10- |
95864-17-8 | ≥98% |
|
32.651376192867 | 10-pyrene-pc | 1-Palmitoyl-2-pyrenedecanoyl Phosphatidylcholine | sPLA2s substrates fluorescent PLAs phospholipases fluorescence phospholipids | 32.651376192867 | |||
| 10462 |
11(12)- |
504435-15-8 | ≥98% |
|
✓ | 2010-10-28 | 6.426522176380 | 11-12-epete | 11,12-EEQ; 11,12-Epoxyeicosatetraenoic Acid | eicosapentaenoic acids EPAs epoxyeicosatetraenoic EpETE EETeTr cytochromes P450 epoxygenases CYP450 10-[3-2Z,5Z-octadien-1-yl-2-oxiranyl]-5Z,8Z-decadienoic acid 11,12-epoxyeicosatrienoic acid | 6.426522176380 | |
| 62235 |
1,2- |
89019-63-6 | ≥95% |
|
40.410214855739 | 1-2-bis-heptanoylthio-glycerophosphocholine | Diheptanoyl Thio-PC; 1,2-bis(Heptanoylthio)-1,2-dideoxy-sn-glycero-3-phosphorylcholine | sPLA2s iPLA2s substrates phospholipases PLAs sn-2 cleavage lysophosholipids DTNB DTB detection | 40.410214855739 | |||
| 62210 |
1,2- |
60514-49-0 | ≥95% |
|
3.321436464088 | 1-2-didecanoyl-sn-glycerol | DAG diacylglyceride 1,2-bis-(O-decanoyl)-sn-glycerol analogs | 3.321436464088 | ||||
| 10008646 |
1,2- |
30403-47-5 | ≥95% |
|
✓ | 2007-08-29 | 3.901988950276 | 1-2-dihexanoyl-sn-glycerol | PKCs second messengers diacylglycerols DAG 1,2-dioctanoyl-sn-glycerols proteins kinases snglycerol | 3.901988950276 | ||
| 10009874 |
1,2- |
19191-91-4 | ≥98% |
|
2008-01-11 | 4.741700429711 | 1-2-dioctanoyl-pc | 1,2-Dioctanoyl Phosphatidylcholine | phosphatidylcholines phospholipids cell membranes lipids PLA2 sPLA2 PLD phospholipases PCs | 4.741700429711 | ||
| 62225 |
1,2- |
60514-48-9 | ≥95% |
|
9.433401736385 | 1-2-dioctanoyl-sn-glycerol | DAG diacylglycerol | 9.433401736385 | ||||
| 10009873 |
1,2- |
56648-95-4 | ≥98% |
|
2008-08-20 | 3.969392265193 | 1-2-dioleoyl-pc | 1,2-Dioleoyl-sn-glycero-3-Phosphatidylcholine; DOPC | DOPC Phospholipid bilaye Fatty acid siRNA liposome | 3.969392265193 | ||
| 10007863 |
1,2- |
2442-61-7 | ≥95% |
|
2010-11-10 | 1.801878453039 | 1-2-dioleoyl-rac-glycerol | (±)-1,2-Diolein; rac-Glycerol 1,2-dioleate | diacylglycerols DAGs proteins kinases C PKCs DGKs multisubstrates lipids MuLK 1,2-Di(cis-9-octadecenoyl)-rac-glycerol rac-1,2-dioleoylglycerol Diacylglycerols Diglycerides | 1.801878453039 | ||
| 62230 |
1,2- |
24529-88-2 | ≥95% |
|
4.467049723757 | 1-2-dioleoyl-sn-glycerol | DAG diacylglycerols protein kinase pkc-activating second messengers | 4.467049723757 | ||||
| 10008648 |
1,2- |
30334-71-5 | ≥95% |
|
2008-06-25 | 4.114585635359 | 1-2-dipalmitoyl-sn-glycerol | NSC 269964; 1,2-DPG | PKC proteins kinases C DAG activator | 4.114585635359 | ||
| 9000405 |
13,14- |
475992-30-4 | ≥98% |
|
2009-12-03 | 80.623784530387 | 13-14-dihydro-16-16-difluoro-prostaglandin-e1 | 15-hydroxy Lubiprostone | prostaglandins E1 PGE1 chloride channels Amitiza constipation irritable bowel syndrome platelets dilation vasodilation hypotension metabolite of lubiprostone | 80.623784530387 | ||
| 10704 |
(±)13- |
23017-93-8 | ≥98% |
|
2011-02-24 | 50.689198895028 | -13-hpode | hydroperoxides lipids linoleic acids reactive oxygen species oxidative stress injury | 50.689198895028 | |||
| 10007527 |
14(15)- |
351533-80-7 | ≥98% |
|
✓ | 2012-03-09 | 51.217386433394 | 14-15-epede | 14,15-Epoxyeicosadienoic Acid | epoxides epoxygenases DGLA dihomo- γ-linolenic acids eicosatrienoic ETA cytochromes P450 PUFA monoepoxides 14,15-EpEDE 14,15-EpED-8,11 gamma-linolenic g-linolenic .gamma.-linolenic epoxyeicosadienoic | 51.217386433394 | |
| 10007528 |
14(15)- |
- | ≥90% |
|
✓ | 2012-04-05 | 74.241295273173 | 14-15-epede-methyl-ester | 14,15-Epoxyeicosadienoic Acid methyl ester | epoxide epoxygenase DGLA dihomo-γ-linolenic acid eicosatrienoic acid ETA cytochrome P450 | 74.241295273173 | |
| 18580 |
15- |
537695-15-1 | ≥90% |
|
✓ | 2012-03-28 | 68.276771025169 | 15-deoxy-12-14-prostaglandin-j2-glutathione | 15-deoxy-Δ12,14-PGJ2 Glutathione | adducts cyclopentenone PGJ2 GSH glutathione prostaglandins PGs | 68.276771025169 | |
| 10169 |
15(S)- |
161744-53-2 | ≥98% |
|
19.370883977900 | 15-s-hete-ethanolamide | 15(S)-HAEA | neurotransmitters ethanolamides fatty acids endocannabinoids CB receptors amide hydrolases FAAH neurochemistry neuroscience ethanolamines 15HETE cannabinoids cbs synthetic | 19.370883977900 | |||
| 10005099 |
17(R)- |
155976-53-7 | ≥98% | ✓ | 2005-01-05 | 25.056148382005 | 17-r-hdohe | 17(R)-hydroxy Docosahexaenoic Acid | resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry | 25.056148382005 | ||
| 10009799 |
17(S)- |
- | ≥98% |
|
2007-03-12 | 13.789244935543 | 17-s-hdohe | 17(S)-hydroxy Docosahexaenoic Acid | resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe | 13.789244935543 | ||
| 10010188 |
1- |
52603-03-9 | ≥98% |
|
2007-11-10 | 18.690441988950 | 1-hexadecyl-lysophosphatidic-acid | AGP 16:0; 1-Hexadecyl-2-hydroxy-sn-glycero-3-phosphate; Alkyl glycero phosphate 16:0 | LPAs G-proteins Gproteins GPCRs cell proliferation smooth muscles contractions platelet aggregation neurite retraction | 18.690441988950 | ||
| 10010292 |
1- |
- | ≥98% |
|
✓ | 2007-11-10 | 18.601975138121 | 1-hexadecyl-lysophosphatidic-acid-sodium-salt | AGP 16:0 (sodium salt); 1-Hexadecyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt); Alkyl glycero phosphate 16:0 (sodium salt) | LPAs G-protein Gprotein GPCRs cell proliferations smooth muscles contractions platelet aggregation neurite retraction | 18.601975138121 | |
| 62600 |
1- |
86390-77-4 | ≥90% |
|
2.030269337016 | 1-oleoyl-2-acetyl-sn-glycerol | OAG | OAG DAG oleoyl glycerol diacylglycerol | 2.030269337016 | |||
| 10010093 |
1- |
65528-98-5 | >95% |
|
✓ | 2007-08-29 | 30.284604051565 | 1-oleoyl-lysophosphatidic-acid | Oleoyl-sn-3-Glycerophosphate; 1-Oleoyl LPA | LPAS 1-oleoyl-LPAS agonists GPCR G-proteins cell proliferation smooth muscle contraction platelet aggregation reurite retraction | 30.284604051565 | |
| 62215 |
1- |
22556-62-3 | ≥95% |
|
47.041025168815 | 1-oleoyl-lysophosphatidic-acid-sodium-salt | Oleoyl-sn-3-glycerophosphate | LPA analogs | 47.041025168815 | |||
| 10007072 |
1- |
26662-95-3 | ≥98% |
|
2005-12-20 | 21.209455406471 | 1-palmitoyl-2-linoleoyl-pe | PLPE; Phosphatidyl Ethanolamine (1-palmitoyl, 2-linoleoyl) | phosphoethanolamines phosphatidylethanolamines lipids biosynthesis lysophospholipases anandamides biochemical pathways fatty acids cellular membranes A2 D substrates sPLA2-IIA | 21.209455406471 | ||
| 62660 |
1- |
2680-59-3 | >85% |
|
6.548570441988 | 1-palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol | POL | USP sesame oils glycerols OOL triglycerides analysis lipids | 6.548570441988 | |||
| 10010094 |
1- |
22002-85-3 | ≥98% |
|
2010-11-29 | 9.517127071823 | 1-palmitoyl-lysophosphatidic-acid | 1-Palmitoyl LPA (free acid) | GPCR G-proteins cells proliferation smooth muscles contractions platelets aggregation | 9.517127071823 | ||
| 10010290 |
1- |
- | >98% |
|
✓ | 2007-09-05 | 16.371922651933 | 1-palmitoyl-lysophosphatidic-acid-sodium-salt | 1-Palmitoyl LPA | 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate monopalmitoylphosphatidic acid MPPA LPAS GPCRs biological responses | 16.371922651933 | |
| 60925 |
2- |
- | >98% |
|
19.089171270718 | 2-o-ethyl-paf-c-16 | platelet-activating factors PAFs analogs agonists | 19.089171270718 | ||||
| 60902 |
2- |
78858-44-3 | >98% |
|
10.577513812155 | 2-o-methyl-paf-c-16 | PAFs platelet-activating factors analogs methyl inhibits inhibitors tumors cells | 10.577513812155 | ||||
| 60912 |
2- |
77286-66-9 | >98% |
|
6.188022099447 | 2-o-methyl-paf-c-18 | Edelfosine; ET-18-OCH3; 1-O-octadecyl-2-O-methyl-sn-glyceryl-3-phosphorylcholine | PAFs platelet-activating factors anticancer analogs | 6.188022099447 | |||
| 10005707 |
(2S)- |
- | ≥98% |
|
2005-10-19 | 33.258149171270 | -2s-ompt | GPR lysophosphatidic acids lipids mediators receptors LPA1/Edg-2 LPA2/Edg-4 LPA3/Edg-7 LPA4/GPR23 agonists calcium mobilization Sf9 cells (2R)-OMPT release assays LPA3-transfected rat hepatoma Rh7777 | 33.258149171270 | |||
| 60945 |
2- |
96801-55-7 | ≥98% |
|
39.283701657458 | 2-thio-paf | 2-thio-PAFs platelet-activating factors PAF-AH substrates agonists analogs PAF-acetylhydrolases receptors lysophospholipases | 39.283701657458 | ||||
| 10467 |
5,6- |
845673-97-4 | ≥97% |
|
✓ | 2011-06-13 | 10.125051302288 | 5-6-dihete | eicosapentaenoic acids EPAs cytochromes P450 P-450 metabolites polyunsaturated fatty metabolites ω-3 omega epoxidation 5(6)-DiHETE DiHETEs epoxide hydrolases CYP450 | 10.125051302288 | ||
| 9000314 |
7(Z),11(Z)- |
104410-91-5 | ≥98% |
|
✓ | 2009-03-06 | 6.706104972376 | 7-z-11-z-nonacosadiene | pheromone drosophila d. melanogaster elongase | 6.706104972376 | ||
| 9000531 |
7(Z),11(Z)- |
127599-39-7 | ≥98% |
|
✓ | 2009-12-04 | 17.361027624309 | 7-z-11-z-pentacosadiene | pheromones fruits flies Drosophilia copulation hydrocarbon dienes courtship sex elongase eloF 7,11-pentacosadiene 7,11-PD | 17.361027624309 | ||
| 60904 |
Arachidonoyl PAF C- |
86288-11-1 | >98% |
|
6.211408839779 | arachidonoyl-paf-c-16 | 1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-Phosphocholine | PAFs platelet-activating factors arachidonic | 6.211408839779 | |||
| 10006797 | Araguspongin B | 123000-02-2 | >90% |
|
2005-09-09 | 45.826433394721 | araguspongin-b | membrane-permeable antagonists inositols inositol-1,4,5-triphosphates receptors marine products Pacific basin sponges vasodilatory properties signal transductions messengers IP3 promotes mobilization calcium Ca2+ intracellular stores antagonizes calcium-releasing actions cerebral microsomes Xestospongin C neuroscience | 45.826433394721 | |||
| 10005292 | Atherosclerosis Product Pack | - | 2004-09-09 | 4.426165745856 | atherosclerosis-product-pack | Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis inhibitors inhibits inhibition CETP WB blots blotting IHC immunohistochemistry JTT-705 89450 packs | 4.426165745856 | |||||
| 60924 | Azelaoyl PAF | - | >98% |
|
43.427316495658 | azelaoyl-paf | PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors | 43.427316495658 | ||||
| 10008612 |
azido- |
- | ≥98% |
|
2006-09-13 | 52.768238182934 | azido-fty720 | sphingosine 1 phosphate S1P1 S1P3 S1P4 S1P5 immunosuppressant kinases photoreactive agonists analogs allograft transplants inhibits inhibitors inhibition lymphocytes emigration lymphoid organs in vivo Azido FTY720 FTY 720 | 52.768238182934 | |||
| 10507 |
Bio- |
- |
|
2010-06-15 | 50.222077348066 | bio-active-lipid-ii-screening-library-96-well | vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandins HTS high thoroughput screening | 50.222077348066 | ||||
| 10506 |
Bio- |
- |
|
2010-06-15 | 39.676215469613 | bio-active-lipid-i-screening-library-96-well | vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandins HTS high thoroughput screening cannabinoids cbs synthetic | 39.676215469613 | ||||
| 60928 | Butanoyl PAF | - | >98% |
|
5.806546961326 | butanoyl-paf | ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis | 5.806546961326 | ||||
| 60929 | Butenoyl PAF | - | >98% |
|
3.819160220994 | butenoyl-paf | ox-LDL signaling molecules oxLDL oxidized low-density lipoproteins PMNL polymorphonuclear leukocytes platelet-activating factors atherosclerosis | 3.819160220994 | ||||
| 10005067 | CAY10434 | - | >98% |
|
2005-01-19 | 13.084198895027 | cay10434 | CYP20-HETE CYP450 cytochromes renal kidney metabolites arachidonic acid enzymes CYP4A11 inhibits inhibitors inhibition imidazoles | 13.084198895027 | |||
| 10005033 | CAY10444 Exclusive | 298186-80-8 | ≥98% |
|
✓ | 2004-10-05 | 58.748941068140 | cay10444 | BML-241 | receptors antagonists S1P3 EDG3 sphingosines sphingosine-1 sphingosine1 phosphates Hela cells G-proteins CAY-10444 BML241 | 58.748941068140 | |
| 10006400 | CAY10462 | 502656-68-0 | >98% |
|
2005-01-19 | 30.100883977900 | cay10462 | hydroxy eicosatetraenoic acids 20-HETEs CYP450 cytochromes renal kidney metabolites arachidonic enzymes CYP4A inhibits inhibitors inhibition metabolism CAY10434 dihydrochlorides selective selectivity synthases | 30.100883977900 | |||
| 10562 | CAY10631 Exclusive | - | ≥95% |
|
✓ | 2011-02-10 | 0.281767955801 | cay10631 | Very long chain fatty acids docosahexaenoic elongases retinas macular diseases rhodopsin | 0.281767955801 | ||
| 10497 | CAY10632 Exclusive | 105517-82-6 | ≥98% |
|
✓ | 2011-03-14 | 0.348066298342 | cay10632 | very long chain fatty acids VLCPUFA retinas macular diseases ELOVL4 dotriacontahexaenoic FA-4 FA4 retinal macular degeneration | 0.348066298342 | ||
| 10857 | CAY10654 Exclusive | 1298023-69-4 | ≥98% |
|
✓ | 2011-06-21 | 1.903637200736 | cay10654 | CAY-10654 CAY 10654 quorum sense sensing signal signaling genes regulations infectious diseases lipids bacteria pseudomonas aeruginosa AHLs p. N-acylated-L-Homoserine lactones transcriptional activators LasR virulence factors immunosuppression leukocytes lymphocytes concanavalin A cytotoxicity | 1.903637200736 | ||
| 10007289 |
cis- |
122068-08-0 | ≥98% |
|
✓ | 2006-07-19 | 35.594640883978 | cis-4-10-13-16-docosatetraenoic-acid | PUFAs polyunsaturated fatty acids rat testis lipids | 35.594640883978 | ||
| 10006866 |
cis- |
- | ≥98% |
|
2006-07-19 | 35.609005524862 | cis-4-10-13-16-docosatetraenoic-acid-methyl-ester | methyl esters polyunsaterated fatty acids PUFAs rat testis lipids lipophilic | 35.609005524862 | |||
| 10005432 | DDA | 25152-84-5 | ≥98% |
|
2004-07-22 | 15.831790055248 | dda | trans-2,4-Decadien-1-al; Decadienealdehyde | lipoxygenases diatoms alkyls linoleic acids dihomo-gamma-linolenic dihomo-g-linolenic arachidonic dihomo-.gamma.-linolenic carcinoma Caco2 apoptosis | 15.831790055248 | ||
| 10007945 |
D- |
764-22-7 | ≥98% |
|
2010-08-10 | 15.444741336011 | d-erythro-sphinganine | D-erythro-Dihydrosphingosine | ceramide sphingosine sphingosine kinases sphinganine-1-phosphates mycotoxins fumonisins cancers protein kinase C PKC spingosine-1-phosphates cell signaling octadecasphinganine Dihydro-C18-sphingosine SPC 102860 SPC102860 signalling SPC-102860 | 15.444741336011 | ||
| 10007901 |
D- |
86555-28-4 | ≥98% |
|
2010-08-20 | 4.873907584128 | d-erythro-sphingosine-c-15 | sphingosines internal standard 10007907 unsaturated hydrocarbon chain 18-carbon 18 carbons dihydrosphingosine mammalian tissues | 4.873907584128 | |||
| 10007902 |
D- |
6918-48-5 | ≥98% |
|
2010-08-20 | 3.431315921647 | d-erythro-sphingosine-c-17 | sphingosines kinases internal standard C17 C 17 human skin sphingoid chromatographic spectrometric dihydrosphingosine 10007907 | 3.431315921647 | |||
| 10007903 |
D- |
6918-49-6 | ≥98% |
|
2008-11-21 | 10.081802486187 | d-erythro-sphingosine-c-20 | sphingosines sphingolipids ceramides C-18 C18 C20 gangliosides brain development neurodegenerations | 10.081802486187 | |||
| 60901 |
Dihomo- |
155575-01-2 | >98% |
|
5.288756906077 | dihomo-linolenoyl-paf-c-16 | 1-O-hexadecyl-2-dihomo-γ-Linolenoyl-sn-glycero-3-Phosphocholine | PAFs platelet-activating factors Dihomo-gamma-Linolenoyl dihomo-g-linolenyl dihomo-.gamma.-linolenoyl | 5.288756906077 | |||
| 11219 |
DMABA- |
1175002-05-7 | 9% deuterated forms (d1-d10) |
|
2012-02-15 | 0E-12 | dmaba-d10-nhs-ester | GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers | 0E-12 | |||
| 11217 |
DMABA- |
1175002-03-5 | ≥99% deuterated forms (d1-d4) |
|
2012-02-15 | 0E-12 | dmaba-d4-nhs-ester | DMABA N-hydroxysuccinimide ester-d4; N-Succinimidyl 4-(dimethylamino)benzoate-d4; 4-(dimethylamino) Benzoic Acid-d4 | GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers | 0E-12 | ||
| 11218 |
DMABA- |
1175002-04-6 | ≥99% deuterated form (d1-d6) |
|
2012-02-07 | 0E-12 | dmaba-d6-nhs-ester | DMABA N-hydroxysuccinimide ester-d6; 4-(dimethylamino) Benzoic Acid-d6; N-Succinimidyl 4-(dimethylamino)benzoate-d6 | GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers | 0E-12 | ||
| 11216 | DMABA NHS ester New | 58068-85-2 | ≥98% |
|
2012-01-19 | 0E-12 | dmaba-nhs-ester | N-Succinimidyl 4-(dimethylamino)benzoate; DMABA N-hydroxysuccinimide ester; 4-(dimethylamino) Benzoic Acid | phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes MS mass spectrometry electorspray tandem PE lipids markers | 0E-12 | ||
| 63180 | DMAPP (ammonium salt) | 1186-30-7 | ≥95% |
|
56.548066298342 | dmapp-ammonium-salt | Dimethylallyl Pyrophosphate (ammonium salt) | prenylation signal transduction | 56.548066298342 | |||
| 60980 |
D- |
210488-61-2 | ≥98% |
|
21.776631739379 | d-myo-inositol-1-3-4-5-tetraphosphate-sodium-salt | Ins(1,3,4,5)-P4; 1,3,4,5-IP4 | IP4 inositols tetraphosphates salts phosphorylation 1,4,5-triphosphate-3-kinase intracellular calcium InsPs | 21.776631739379 | |||
| 60972 |
D- |
- | ≥98% |
|
18.030503053213 | d-myo-inositol-1-3-4-triphosphate-sodium-salt | Ins(1,3,4)-P3 (sodium salt); 1,3,4-IP3 (sodium salt) | inositols ins(1,3,4)ip3 second messengers salts calcium channels ca2+ ca++ inositol-1-kinases triphosphates oligophophates isomers signal transduction InsPs | 18.030503053213 | |||
| 60960 |
D- |
103476-24-0 | ≥98% |
|
25.118868426437 | d-myo-inositol-1-4-5-triphosphate-potassium-salt | Ins(1,4,5)-P3 (potassium salt); 1,4,5-IP3 (potassium salt) | IP3 inositols triphosphates salts phosphorylation receptors messengers inositol-4,5-biphosphate hydrolysis intracellular calcium PLC phospholipases InsPs | 25.118868426437 | |||
| 10006305 |
D- |
35922-06-6 | ≥98% |
|
✓ | 2005-02-23 | 16.744126481115 | d-nmappd | CAY10466; (1R,2R)-B13 | ceramides inhibitors cancers cells inhibits inhibition ceramidase apoptosis colorectal keratinocytes melanoma lines viability inducers induces | 16.744126481115 | |
| 60903 |
Docosahexaenoyl PAF C- |
132213-85-5 | ≥98% |
|
5.288756906077 | docosahexaenoyl-paf-c-16 | PAFs platelet-activating factors DHA | 5.288756906077 | ||||
| 60907 |
Eicosapentaenoyl PAF C- |
132196-28-2 | ≥98% |
|
4.846201657458 | eicosapentaenoyl-paf-c-16 | PAFs platelet-activating factors EPA | 4.846201657458 | ||||
| 13269 | Farnesyl Alcohol Azide | - | ≥95% |
|
2010-04-05 | 10.328288790669 | farnesyl-alcohol-azide | Click Tag™ Farnesyl Alcohol Azide | farnesylation posttranslational modifications isoprenoids click chemistry bioconjugation click-it Farnesyldiphosphate Farnesyldiphosphate Farnesyltransferase Farnesyl Diphosphate Farnesyltransferase Presqualene Diphosphate Synthase FPP FPP Farnesyl Transferase Squalene Synthetase Squalene Synthase | 10.328288790669 | ||
| 70440 | Filipin III | 480-49-9 | ≥85% |
|
63.282044198895 | filipin-iii | Filipin-3 Filipin-III Cholesterol fluorescent fluorescence atherosclerosis filipin 111 | 63.282044198895 | ||||
| 62580 | Fumonisin B1 | 116355-83-0 | ≥98% |
|
69.072419217297 | fumonisin-b1 | sphingosines inhibitors apoptosis ceramides | 69.072419217297 | ||||
| 10011347 |
Glycerophospho- |
201738-25-2 | ≥97% |
|
✓ | 2009-03-13 | 18.765230202578 | glycerophospho-n-arachidonoyl-ethanolamine | Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE | anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic | 18.765230202578 | |
| 10009880 | GW 590735 Exclusive | 622402-22-6 | ≥98% |
|
✓ | 2007-06-18 | 9.053149171270 | gw-590735 | PPAR PPAR.alpha. PPAR.BETA. PPAR.gamma. PPAR.delta. receptor transcription factors lipidtriglyceride TG lipoprotein VLDL ApoCIII ApoA1 HDL atherosclerosis endocrinology | 9.053149171270 | ||
| 10670 | Heneicosapentaenoic Acid New | 24257-10-1 | ≥95% |
|
2012-05-01 | 105.555555555555 | heneicosapentaenoic-acid | HPA | fatty acids lipids cyclooxygenases 5-lipoxygenases prostaglandins H PGH synthases PGHS DHA COX 5-LO 5-LOX EPA arachidonic Bryopsis B. pennata fish oils eicosapentaenoic docosahexaenoic linoleic acid green alga algea DELTA6 .DELTA.6 Δ6 DELTA-6 .DELTA.-6 Δ-6 DELTA 6 .DELTA. Δ positions omega-3 .omega.-3 ω-3 omega3 .omega.3 ω3 omega 3 .omega. ω phospholipids triacylglycerols in vivo synthesis | 105.555555555555 | ||
| 10006809 |
Heptanoyl thio- |
- | ≥98% |
|
2005-10-05 | 4.510911602210 | heptanoyl-thio-pc | sPLA2s substrates colorimetrics phospholipases thioesters analogs glycerophospholipids Ellman's reagent measurements activity diheptanoyl thio-PC ether-linked saturated C16 moiety sn-1 position modifications resistant PLA1 pig porcine pancreatic bee venom | 4.510911602210 | |||
| 60920 | Hexadecyl Acetyl Glycerol | 77133-35-8 | ≥90% |
|
11.729917127072 | hexadecyl-acetyl-glycerol | HAG | diacylglycerols DAG 1-O-hexadecyl-2-O-acetyl-sn-glycerol signal transduction inhibits inhibitors apoptosis | 11.729917127072 | |||
| 60930 | Hexadecyl Methyl Glycerol | 96960-92-8 | ≥98% |
|
9.016270718232 | hexadecyl-methyl-glycerol | 1-O-hexadecyl-2-O-methyl-sn-Glycerol | PAF analogs | 9.016270718232 | |||
| 60905 |
Hexanolamino PAF C- |
137566-83-7 | ≥98% |
|
5.288756906077 | hexanolamino-paf-c-16 | PAFs platelet-activating factors analogs hexanolamino antagonists ROS reactive oxygen species | 5.288756906077 | ||||
| 10006350 |
HU- |
112924-45-5 | ≥98% |
|
2005-03-30 | 101.370524861878 | hu-211 | Dexanabinol | HU211 endocannabinoids cannabis CB2 pain inflammation NF-kB NF-.kappa.B inhibition antioxidants neurochemistry terpene-based psychomotor DELTA9-THC .DELTA.9-THC D9-THC neuroprotective cannabidiols CB1 inflammatory pharmacology neuroscience neurochemistry | 101.370524861878 | ||
| 9000326 | Linoleoyl Glycine | 2764-03-6 | ≥98% |
|
2008-10-29 | 3.413839779005 | linoleoyl-glycine | N-Linoleoyl Glycine; LinGly; Glycine Linoleamide | arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs | 3.413839779005 | ||
| 10010541 |
L- |
25695-95-8 | >98% |
|
2008-01-22 | 21.623130755064 | l-threo-sphingosine-c-18 | D-erythro-sphingosine sphingolipids ceramides serines palmitoyltransferases protein kinases C cells proliferations cytoskeletal organization inhibitor inhibition inhibits PKCsSPTs | 21.623130755064 | |||
| 70920 | LY294002 | 154447-36-6 | >98% |
|
71.766895436873 | ly294002 | phosphatidylinositols PI3-kinase inhibitors inhibits PI3K inhibition ly 294002 | 71.766895436873 | ||||
| 60906 |
Lyso- |
52691-62-0 | >98% |
|
5.767182320442 | lyso-paf-c-16 | PAFs platelet-activating factors | 5.767182320442 | ||||
| 60916 |
Lyso- |
74430-89-0 | ≥98% |
|
3.363342541436 | lyso-paf-c-18 | PAFs platelet-activating factors | 3.363342541436 | ||||
| 10010228 |
Lyso- |
- | ≥99% deuterated forms (d1-d4) |
|
✓ | 2010-11-03 | 18.899071823204 | lyso-paf-c-18-d4 | PAFs platelet-activating factors deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS | 18.899071823204 | ||
| 10172 |
Lyso- |
17364-16-8 | >98% |
|
2004-03-02 | 15.121431441487 | lyso-pc | lysopc signals transduction pathways G2A receptors lipids phosphatidylcholines phospholipases PLAs hydrolysis lysophosphatidic acid lysophosphatidyl choline LPA | 15.121431441487 | |||
| 10007947 |
Lyso- |
1670-26-4 | ≥98% |
|
2010-12-07 | 40.824762430939 | lyso-sphingomyelin | sphingomyelins lipids sphingosines deacylases autotaxin sphingosine-1-phosphates lipoproteins dermatitis Niemann-Pick diseases sphingosylphosphorylcholine SPC sphingosylphosphocholine PCs | 40.824762430939 | |||
| 60908 |
Methylcarbamyl PAF C- |
91575-58-5 | >98% |
|
30.302860650706 | methylcarbamyl-paf-c-16 | PAFs platelet-activating factors analogs agonists | 30.302860650706 | ||||
| 9000332 |
Methylcarbamyl PAF C- |
- | ≥98% |
|
✓ | 2009-02-25 | 11.841353591160 | methylcarbamyl-paf-c-8 | Methylcamyl PAF Methylcamyl PAF C-8 Methylcamyl PAF C-16 PAF C-16 PAF-AH Platelet aggregation c-myc c-fos MAP kinase Mitogen-activated kinase G1 Cell cycle PAF | 11.841353591160 | ||
| 10007895 |
N- |
168982-69-2 | ≥98% |
|
2006-07-26 | 40.818766238614 | n-3-oxo-dodecanoyl-l-homoserine-lactone | 3-oxo-C12-HSL | quorum sensing bacteria cystic fibrosis acylhomoserine lactones HSL 3-oxo-C12-HSL 3-(oxo-dodecanoyl)-L-homoserine IL-8 iloprost 3-oxo-C12-Homoserine lactone | 40.818766238614 | ||
| 10011238 |
N- |
- | ≥98% |
|
✓ | 2009-03-30 | 23.139723756906 | n-3-oxo-hexadec-11-z-enoyl-l-homoserine-lactone | 3-oxo-C16:1-Δ11cis-(L)-HSL | 3-O-C16:1-Δ11cis-(L)-HSL AHL quorum sensing signaling autoinducers bacteria Agrobacterium vitis signalling signals HSLs | 23.139723756906 | |
| 10011206 |
N- |
147795-39-9 | ≥98% |
|
2009-06-29 | 6.005074149461 | n-3-oxo-octanoyl-l-homoserine-lactone | N-β-oxo-octanoyl-L-Homoserine lactone; 3-oxo-C8-HSL | AHLs quorum sensing signaling signalling autoinducer gram negative bacterias cells cell-cell communivation A.tumefaciens lactones | 6.005074149461 | ||
| 13213 |
N- |
482598-46-9 | ≥98% |
|
2009-07-08 | 15.720514070071 | n-3-oxo-tetradec-7-z-enoyl-l-homoserine-lactone | 3-oxo-C14:1-Δ7cis-(L)-HSL | AHLs quorum sensing antimicrobial biofilm signaling signalling SAR QSAR immune suppressions bacteria inhibitis inhibitior inhibition | 15.720514070071 | ||
| 13063 |
N- |
177158-19-9 | ≥98% |
|
✓ | 2009-01-29 | 21.390107239333 | n-3-oxo-tetradecanoyl-l-homoserine-lactone | N-3-oxo-myristoyl-L-Homoserine lactone; 3-oxo-C14-HSL | quorum sensing bacteria biofilm gene expressions growth putisolvin lactones HSLs | 21.390107239333 | |
| 63270 |
N- |
135304-07-3 | ≥98% |
|
45.228692449355 | n-acetyl-s-farnesyl-l-cysteine | AFC | inhibitors SAM methyltransferase methylation inhibits cysteines S-adenosylmethionine-dependent | 45.228692449355 | |||
| 63340 |
N- |
139332-94-8 | ≥98% |
|
24.297716390423 | n-acetyl-s-geranylgeranyl-l-cysteine | AGGC | SAM methyltransferase inhibits inhibitors methylation substrate S-adenosylmethionine-dependent cysteines | 24.297716390423 | |||
| 10011300 |
NBD- |
- | ≥95% |
|
✓ | 2009-03-27 | 6.365220994475 | nbd-stearoyl-2-arachidonoyl-sn-glycerol | NBD-SAG | fluorescent DAG PKC second messengers diacylglycerols signaling activators ERK MAPK RasGRP binding | 6.365220994475 | |
| 10011204 |
N- |
202284-85-3 | ≥98% |
|
✓ | 2008-10-06 | 4.688287292817 | n-butyryl-l-homocysteine-thiolactone | bacterial quorum sensing signaling molecules cell density transcriptional regulators LuxIR protein synthesis N-acylhomoserine lactones AHL cellular metabolism autoinduction | 4.688287292817 | ||
| 10007898 |
N- |
67605-85-0 | ≥95% |
|
2006-04-20 | 24.344548879520 | n-butyryl-l-homoserine-lactone | C4-HSL | bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence slime biofilms transduction activation signalling | 24.344548879520 | ||
| 10007899 |
N- |
- | ≥99% deuterated forms (d1-d5) |
|
2006-05-05 | 15.902984918620 | n-butyryl-l-homoserine-lactone-d5 | C4-HSL-d5 | GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence slime biofilms transduction activation signalling | 15.902984918620 | ||
| 10011201 |
N- |
177315-87-6 | ≥96% |
|
2008-09-19 | 13.147814643372 | n-decanoyl-l-homoserine-lactone | C10-HSL | bacterial quorums sensing signaling molecules regulatory cells density infections transcriptional regulators LuxIR N-acylhomerine lactones AHL cellular metabolism virulence | 13.147814643372 | ||
| 10007288 |
N- |
- | ≥98% |
|
2005-12-29 | 0.491139502762 | n-docosanoyl-taurine | neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic | 0.491139502762 | |||
| 9000710 |
N- |
- | ≥95% |
|
✓ | 2011-01-17 | 32.394512169628 | n-dodecanoyl-l-homoserine-lactone-3-hydrazone-biotin | N-dodecanoyl-L-HSL-3-hydrazone-biotin | quorum sensing proteolysis affinity probes avidin lactones HSLS biotinamide biotinimide biotins | 32.394512169628 | |
| 9000711 |
N- |
- | ≥98% |
|
2011-01-19 | 36.070322532477 | n-dodecanoyl-l-homoserine-lactone-3-hydrazone-fluorescein | N-dodecanoyl-L-HSL-3-hydrazone-fluorescein | quorum sensing proteolysis fluorescent probes lactones | 36.070322532477 | ||
| 10011198 |
N- |
177158-20-2 | ≥98% |
|
2008-09-25 | 11.434422761052 | n-heptanoyl-l-homoserine-lactone | C7-HSL | bacterial quorums sensing signaling molecules regulatory cells density infections transcriptional regulators LuxIR N-acylhomoserine latones AHL cellular metabolism virulence | 11.434422761052 | ||
| 13064 |
N- |
87206-01-7 | ≥95% |
|
2009-04-06 | 23.401272875085 | n-hexadecanoyl-l-homoserine-lactone | C16-HSL; N-palmitoyl-L-Homoserine | AHL quorum sensing signaling nitrogen fixing membranes vesicles bacteria signalling LUXI SinI | 23.401272875085 | ||
| 10007896 |
N- |
147852-83-3 | ≥98% |
|
2006-04-20 | 23.942372933920 | n-hexanoyl-l-homoserine-lactone | C6-HSL | bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence cystic fibrosis slime biofilms agriculture aquaculture food spoilage septicemia fish activation transduction signalling | 23.942372933920 | ||
| 10007897 |
N- |
- | ≥99% deuterated forms (d1-d3) |
|
2006-05-05 | 16.918012667363 | n-hexanoyl-l-homoserine-lactone-d3 | C6-HSL-d3 | GC/MS deuteriums isotopes internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry spectoscopy bacterial quorums sensing signaling molecules regulatory regulates systems genes expressions cells density infections transcriptional regulators LuxIR proteins synthesis N-acylhomoserine lactones AHL cellular metabolism regulation virulence cystic fibrosis slime biofilms agriculture aquaculture food spoilage septicemia fish activation transduction signalling | 16.918012667363 | ||
| 10007286 |
N- |
807370-75-8 | >98% |
|
2005-12-21 | 0.529526440410 | n-lignoceroyl-taurine | neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic | 0.529526440410 | |||
| 10007287 |
N- |
- | >98% |
|
2005-12-29 | 0.529526440410 | n-nervonoyl-taurine | neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic | 0.529526440410 | |||
| 16868 |
N- |
177158-21-3 | ≥98% |
|
2009-03-20 | 22.826963752426 | n-nonanoyl-l-homoserine-lactone | C9-HSL | AHL quorum sensing signaling autoinducer bacteria signalling signals auto-inducer acyl rare odd-numbered carbon C9-(L)-HSL | 22.826963752426 | ||
| 13209 |
N- |
479050-96-9 | ≥98% |
|
✓ | 2009-03-30 | 13.287400925787 | n-octadecanoyl-l-homoserine-lactone | C18-HSL | C18-(L)-HSL AHLs quorum sensing signaling nitrogen fixing membrane vesicles bacteria signalling signals hydrophobic | 13.287400925787 | |
| 10011199 |
N- |
147852-84-4 | ≥98% |
|
2008-10-06 | 10.260212494687 | n-octanoyl-l-homoserine-lactone | OHL; C8-HSL | bacterial quorum sensing signaling molecules cell density transcriptional regulators LuxIR protein synthesis N-acylhomoserine lactones AHL cellular metabolism infection virulence cystic fibrosis | 10.260212494687 | ||
| 13058 |
N- |
- | ≥98% |
|
2008-10-17 | 1.935911602210 | n-oleoyl-l-serine | lipids bones endogenous anabolic activity activities formation resorption cannabinoids cbs synthetic | 1.935911602210 | |||
| 10009020 |
N- |
2441-41-0 | ≥98% |
|
2009-12-01 | 2.330883977901 | n-palmitoyl-glycine | N-Hexadecanoyl-Glycine; PalGly | pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines | 2.330883977901 | ||
| 13094 |
N- |
182359-66-6 | ≥98% |
|
✓ | 2009-03-02 | 20.503421432482 | n-pentadecanoyl-l-homoserine-lactone | C15-HSL | C15HSL C15-HSL AHL quorum sensing signaling signalling autoinducers bacterias | 20.503421432482 | |
| 13093 |
N- |
878627-21-5 | ≥98% |
|
✓ | 2009-03-09 | 23.752078542631 | n-tridecanoyl-l-homoserine-lactone | C13-HSL | C13HSL AHL quorum sensing signaling signalling autoinducers bacterias C13-L-HSL | 23.752078542631 | |
| 16827 |
N- |
216596-71-3 | ≥98% |
|
2009-03-09 | 25.914556837817 | n-undecanoyl-l-homoserine-lactone | C11-HSL | AHLs quorum sensing signaling signalling autoinducer bacteria | 25.914556837817 | ||
| 10011207 |
N- |
143537-62-6 | ≥95% |
|
2009-05-28 | 25.300024865124 | n-ketocaproyl-l-homoserine-lactone | 3-O-C6-(L)-HSL | 3-oxo-C6-HSL AHL quorum sensing signaling autoinducers bacteria cell-cell communication V. fischeri | 25.300024865124 | ||
| 10010299 |
Oleoyl 3- |
- | ≥95% |
|
✓ | 2009-10-14 | 15.632520718232 | oleoyl-3-carbacyclic-phosphatidic-acid | 3-ccPA 18:1 | cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA oleate transcellular migration MM1 cells mesothelial autotoxin cancer survival growth migration invasion metastasis antagonist LPA1 LPA2 LPA3 476310-24-4 | 15.632520718232 | |
| 60900 |
PAF C- |
74389-68-7 | >98% |
|
13.996712707182 | paf-c-16 | Platelet-activating Factor C-16 | PAFs platelet-activating factors atherosclerosis | 13.996712707182 | |||
| 60910 |
PAF C- |
74389-69-8 | >97% |
|
17.985480662983 | paf-c-18 | PAFs platelet-activating factors atherosclerosis | 17.985480662983 | ||||
| 10010229 |
PAF C- |
- | ≥99% deuterated forms (d1-d4) |
|
✓ | 2010-11-03 | 18.859116022099 | paf-c-18-d4 | PAFs platelet-activating factors atherosclerosis deuterateds deuterium mass spectrometry MS LC/MS GC/MS LC-MS GC-MS | 18.859116022099 | ||
| 13266 | Palmitic Acid Alkyne New | 99208-90-9 | ≥95% |
|
2012-03-12 | 37.354616399193 | palmitic-acid-alkyne | Click Tag™ Palmitic Acid Alkyne | click chemistry S-palmitoylation click-tag palmitic acids acylation post-translational modifications palmitate proteins | 37.354616399193 | ||
| 10010298 |
Palmitoleoyl 3- |
910228-13-6 | ≥95% |
|
✓ | 2009-11-03 | 11.081066723331 | palmitoleoyl-3-carbacyclic-phosphatidic-acid | 3-carbacyclic PA; 3-ccPA 16:1 | cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitoleate transcellular migration MM1 cells mesothelial autotoxins cancer survival growth migration invasion metastasis NPP2 ENPP2 ectonucleotide pyro phosphatase/phosphodiesterase 2 | 11.081066723331 | |
| 62924 |
PAz- |
117746-89-1 | >98% |
|
2.884056827150 | paz-pc | Azelaoyl PC; 1-Palmitoyl-2-Azelaoyl PC | PPAR.gamma. PPARgamma receptors thiazolidinediones binding sites atherosclerosis | 2.884056827150 | |||
| 10044 | PGPC | 89947-79-5 | >98% |
|
2004-01-21 | 3.828968692449 | pgpc | PPAR.gamma. PPARgamma oxidized LDL lipds agonists atherosclerosis nuclear receptors thiazolidinediones sites peroxisome low-density lipoproteins e-selectin vcam1 vcam-1 binding | 3.828968692449 | |||
| 10009926 | Phosphatidylcholine Assay Kit | - |
|
2007-07-10 | 46.621197053406 | phosphatidylcholine-assay-kit | PC Assay Kit | assays kits ceramides phospholipids atherosclerosis phosphorylcholines phosphocholines glycerol cells membranes fatty acids lipoproteins homeostasis sphingomyelin SM atherosclerosis atherosclerotic lesions serums plasmas quantifying quantification colorimetric PC PLD phospholipases | 46.621197053406 | |||
| 10007839 |
PLC thio- |
- | >98% |
|
2006-01-18 | 12.186710734017 | plc-thio-pip2-sodium-salt | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono | 12.186710734017 | |||
| 10031 |
POV- |
121324-31-0 | >98% |
|
13.112946593001 | pov-pc | 2-(5-oxovaleryl) Phosphatidylcholine | oxidative injury lipids stress oxLDL oxidized low-density lipoproteins CD36 CD-36 PMNLs polymorphonuclear leukocytes atherosclerosis phosphatidylcholines scavengers receptors LPS-binding affinity potent structural determinant inhibits inhibition inhibitors lipopolysaccaride atherosclerosis | 13.112946593001 | |||
| 512031 | Prostaglandin D2 EIA Kit | - |
|
2010-07-19 | 203.609714548802 | prostaglandin-d2-eia-kit | PGD2 ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 203.609714548802 | |||
| 512041 | Prostaglandin D2 Express EIA Kit | - |
|
2010-07-19 | 105.423217169570 | prostaglandin-d2-express-eia-kit | PGD2 Express ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 105.423217169570 | |||
| 9000660 |
PtdIns- |
- | ≥98% |
|
✓ | 2010-09-24 | 11.859666603162 | ptdins-1-2-dihexanoyl-sodium-salt | 1051393-51-1 phosphatidylinositols triphosphates cells signaling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PLS | 11.859666603162 | ||
| 10008099 |
PtdIns- |
- | ≥98% |
|
2006-01-17 | 16.410645224940 | ptdins-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol C-8; DOPI | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | 16.410645224940 | ||
| 10007710 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 17.227729091255 | ptdins-1-2-dipalmitoyl-ammonium-salt | DPPI; Phosphatidylinositol C-16 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | 17.227729091255 | ||
| 10007764 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 13.203405914851 | ptdins-3-4-5-p3-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol-3,4,5-trisphosphate; DOPI-3,4,5-P3 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP3 mono PIPs | 13.203405914851 | ||
| 9000414 |
PtdIns- |
- | ≥98% |
|
✓ | 2009-09-25 | 14.484466638334 | ptdins-3-4-5-p3-1-2-dipalmitoyl-d62-sodium-salt | Phosphatidylinositol-3,4,5-trisphosphate C-16-d62; DPPI-3,4,5-P3-d62 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids PIPs phosphatidylinositols triphosphates phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP3 mono di | 14.484466638334 | |
| 64920 |
PtdIns- |
- | ≥98% |
|
82.191402701043 | ptdins-3-4-5-p3-1-2-dipalmitoyl-sodium-salt | Phosphatidylinositol-3,4,5-triphosphate C-16; DPPI-3,4,5-P3 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids PIPs | 82.191402701043 | |||
| 64930 |
PtdIns- |
- | >98% |
|
11.022156370333 | ptdins-3-4-5-p3-1-stearoyl-2-arachidonoyl-sodium-salt | Phosphatidylinositol-3,4,5-triphosphate C-18 (sodium salt) | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids PIP3 PIPs | 11.022156370333 | |||
| 9000829 |
PtdIns- |
- | 98% |
|
✓ | 2010-08-23 | 29.538729281768 | ptdins-3-4-5-p3-1-stearoyl-2-docosahexaenoyl-sodium-salt | phospholipids phospholipases C PLC inositols tetrakisphosphates IP4 diacylglycerols DAG calcium pleckstrin homology domains | 29.538729281768 | ||
| 10007759 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 12.787000534663 | ptdins-3-4-p2-1-2-dihexanoyl-sodium-salt | Phosphatidylinositol-3,4-bisphosphate C-6; DHPI-3,4-P2 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono PIPs | 12.787000534663 | ||
| 64922 |
PtdIns- |
- | ≥98% |
|
12.877812500000 | ptdins-3-4-p2-1-2-dipalmitoyl-sodium-salt | Phosphatidylinositol-3,4-diphosphate C-16; DPPI-3,4-P2 | phosphatidylinositols diphosphates phospholipids phophorylation signal transduction PIP2 PIPs | 12.877812500000 | |||
| 10007763 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 12.368515653774 | ptdins-3-5-p2-1-2-dioctanoyl-sodium-salt | Phosphatidylinositol-3,5-bisphosphate C-8; DOPI-3,5-P2 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono PIPs | 12.368515653774 | ||
| 64921 |
PtdIns- |
- | ≥98% |
|
25.052209944751 | ptdins-3-p1-1-2-dipalmitoyl-ammonium-salt | DPPI-3-P1 | phosphatidylinositols diphosphates phospholipids phophorylation signal transduction lipids PIP1 | 25.052209944751 | |||
| 10005616 |
PtdIns- |
- | ≥99% deuterated product |
|
2005-12-30 | 13.982187083253 | ptdins-3-p1-1-2-dipalmitoyl-d62-ammonium-salt | DPPI-3-P-d62; Phosphatidylinositol-3-phosphate C16-d62 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP1 triphosphates mono | 13.982187083253 | ||
| 10007762 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 15.920101864641 | ptdins-4-5-p2-1-2-dihexanoyl-sodium-salt | Phosphatidylinositol-4,5-bisphosphate C-6; DHPI-4,5-P2 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono PIPs | 15.920101864641 | ||
| 64910 |
PtdIns- |
- | ≥97% |
|
171.711605459863 | ptdins-4-5-p2-1-2-dioctanoyl-sodium-salt | DOPI-4,5-P2; Phosphatidylinositol-4,5-bisphosphate C-8 | phosphatidylinositols diphosphates phospholipids phophorylation signal transduction PIP2 PIPs | 171.711605459863 | |||
| 64924 |
PtdIns- |
- | ≥98% |
|
20.965551649087 | ptdins-4-5-p2-1-2-dipalmitoyl-ammonium-salt | Phosphatidylinositol-4,5-diphosphate C-16; DPPI-4,5-P2 | phosphatidylinositols diphosphates phospholipids phophorylation signal transduction PIP2 PIPs | 20.965551649087 | |||
| 10008115 |
PtdIns- |
- | ≥98% |
|
2006-01-17 | 27.038152624309 | ptdins-4-5-p2-1-2-dipalmitoyl-sodium-salt | Phosphatidylinositol-4,5-diphosphate C-16; DPPI-4,5-P2 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP2 mono | 27.038152624309 | ||
| 10005615 |
PtdIns- |
- | ≥99% deuterated product |
|
2006-01-30 | 15.227603059923 | ptdins-4-5-p2-1-2-dipamitoyl-d62-sodium-salt | Phosphatidylinositol-4,5-diphosphate C16-d62; DPPI-4,5-P2-d62 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated diacyl glycerols DAG PIP2 triphosphates mono di | 15.227603059923 | ||
| 10008159 |
PtdIns- |
- | ≥98% |
|
2006-12-21 | 22.575276243093 | ptdins-4-5-p2-biotin-sodium-salt | Phosphatidylinositol-4,5-diphosphate C-8-biotin | phosphatidylinositols diphosphates phospholipids phophorylation intracellular signals transduction PIP2 biotinimides dioctanoyl PTEN PI3k affinity probes ligands detection transmembranes receptors nucleic acids proteins binding kinases PIPs biotins biotinylated | 22.575276243093 | ||
| 10007757 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 14.515924077704 | ptdins-4-p1-1-2-dihexanoyl-sodium-salt | DHPI-4-P1; Phosphatidylinositol-4-phosphate C-6 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | 14.515924077704 | ||
| 10007711 |
PtdIns- |
- | ≥97% |
|
2005-12-30 | 12.642461236856 | ptdins-4-p1-1-2-dioctanoyl-ammonium-salt | DOPI-4-P1; Phosphatidylinositol-4-phosphate C-8 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | 12.642461236856 | ||
| 64923 |
PtdIns- |
- | ≥98% |
|
23.464722804343 | ptdins-4-p1-1-2-dipalmitoyl-ammonium-salt | DPPI-4-P1 | phosphatidylinositols diphosphates phospholipids phophorylation signal transduction lipids PIP1 | 23.464722804343 | |||
| 10008050 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 11.847904235727 | ptdins-5-p1-1-2-dihexanoyl-sodium-salt | Phosphatidylinositol-5-phosphate; DHPI-5-P1 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | 11.847904235727 | ||
| 10007758 |
PtdIns- |
- | ≥98% |
|
2005-12-30 | 11.847904235727 | ptdins-5-p1-1-2-dioctanoyl-ammonium-salt | DOPI-5-P1; Phosphatidylinositol-5-phosphate C-8 | phosphatidylinositols triphosphates cellular signals signalling transduction phospholipids phospholipases PLC PLD analogs diacyl glycerols DAG PIP1 mono | 11.847904235727 | ||
| 64925 |
PtdIns- |
- | ≥98% |
|
19.057269956181 | ptdins-5-p1-1-2-dipalmitoyl-ammonium-salt | DPPI-5-P1 | phosphatidylinositols diphosphates phospholipids phophorylation signal transduction lipids PIP1 | 19.057269956181 | |||
| 60909 |
Pyrrolidino PAF C- |
91021-63-5 | >98% |
|
10.577513812155 | pyrrolidino-paf-c-16 | platelet-activating factors PAFs analogs agonists | 10.577513812155 | ||||
| 10012554 | Resolvin D1 Exclusive | 872993-05-0 | ≥95% |
|
✓ | 2008-06-06 | 256.332392917195 | resolvin-d1 | RvD1; 17(S)-Resolvin D1 | EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 | 256.332392917195 | |
| 10006440 | SEW2871 | 256414-75-2 | >98% |
|
2005-03-09 | 81.383655616943 | sew2871 | FTY720 sphingosines 1-phosphates receptor-1 S1P1 agonists immunosuppression brandycardia G-proteins receptors lymphocytes recirculation blood heart rate GPR FTY 720 sew 2871 | 81.383655616943 | |||
| 63260 |
S- |
135784-48-4 | ≥97% |
|
46.433127071822 | s-farnesyl-thioacetic-acid | FTA | SAM inhibits inhibitors analogs methyltransferase S-adenosylmethionine-dependent cysteines | 46.433127071822 | |||
| 10009928 | Sphingomyelin Assay Kit | - |
|
2007-06-29 | 57.152163904235 | sphingomyelin-assay-kit | SM Assay Kit | assays kits ceramides phosphorylcholines lipids cells membranes lipoproteins sphingomyelinases enzymes signals signaling signalling proliferation differentiation growth arrest apoptosis Niemann-Pick disease tissues fluids serums plasmas pathogenesis atherosclerosis quantifying quantification colorimetric | 57.152163904235 | |||
| 10006822 | Sphingosine Kinase 1 Polyclonal Antibody | - |
|
2006-12-21 | 23.619964088397 | sphingosine-kinase-1-polyclonal-antibody | SPHK 1 | proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry sphingosines kinases enzymes sphingolipids metabolisms catalyzes phosphorylation sphingosine-1-phosphates cells proliferation death tissues kidneys livers spleen hearts platelets tumors cytosolic membranes amino acids post translational modifications SK1 SPK1 cancers immunoblotting | 23.619964088397 | |||
| 10004883 | sPLA2 (Type V) Inhibitor Screening Assay Kit | - | 2004-05-07 | 52.717553275453 | spla2-type-v-inhibitor-screening-assay-kit | Secretory Phospholipase A2 (Type V) | assays measures kits inhibition inhibitors phospholipases inflammation eicosanoids colorimetric sPLA2s enzymes diheptanoyl thio-pc | 52.717553275453 | ||||
| 10009055 | TBARS Assay Kit | - |
|
2006-10-13 | 762.237392265193 | tbars-assay-kit | Thiobarbituric Acid Reactive Substances Assay Kit | assays kits MDA malodialdehyde lipid peoxidation cellular injury oxidative stress thiobarbitruic acid reactive substances MDA-TBA adduct colorimetrically | 762.237392265193 | |||
| 10007565 | Tetradecyl Phosphonate | 4671-75-4 | >98% |
|
2005-10-17 | 49.791160220994 | tetradecyl-phosphonate | pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter | 49.791160220994 | |||
| 10539 |
Tetratriaconta- |
105528-06-1 | ≥95% |
|
2011-06-06 | 19.725239410681 | tetratriaconta-16-z-19-z-22-z-25-z-28-z-31-z-hexaenoic-acid | very long chain fatty acids VLCPUFAs ceramides sphingomyelin retinas sperm brains proteins kinases C polyunsaturated | 19.725239410681 | |||
| 60950 |
(±)trans- |
116673-45-1 | ≥98% |
|
4.326817679558 | -trans-2-5-bis-3-4-5-trimethoxyphenyl-1-3-dioxolane | trans-BTP Dioxolane | PAFs antagonists dioxolanes receptors platelet-activating factors (±)trans-2,4-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane | 4.326817679558 | |||
| 10010303 | Triglyceride Colorimetric Assay Kit | - |
|
2007-10-31 | 362.235166605279 | triglyceride-colorimetric-assay-kit | assays kits triglycerides enzymes enzymatic hydrolysis water-insoluble lipids three fatty acids esterified glycerols blood serums lipoproteins chylomicrons very low density VLDLs dietary fats metabolisms energy diagnosis primary secondary hyperlipoproteinemia dyslipidemia triglyceridemia diabetes mellitus nephrosis livers obstruction endocrine colorimetric fluorometric plasmas coupled reaction systems | 362.235166605279 | ||||
| 10006794 |
(+)- |
88840-02-2 | >90% |
|
2006-02-15 | 56.289558011050 | -xestospongin-a | XeA; Araguspongin D | xestospongins marine natural products pcific basin sponges vasodilatory properties inositols phosphates signals transductions messengers IP3 receptors mobilization calcium-releasing Ca2+ intracellular antagonizes inositol-1,4,5-triphosphates cerebral microsomes C antagonists membrane-permeable | 56.289558011050 | ||
| 64950 | Xestospongin C | 88903-69-9 | >90% |
|
172.899215469613 | xestospongin-c | Araguspongine E; XeC | IP3 inositols triphosphates phosphorylation receptors messengers inositol-4,5-biphosphate hydrolysis intracellular calcium PLC phospholipases lipids neuroscience | 172.899215469613 | |||
| 63420 |
α- |
148796-53-6 | ≥98% |
|
2006-12-01 | 26.177613259668 | -hydroxy-farnesyl-phosphonic-acid | Hydroxyfarnesyl Phosphate | FPTase inhibitors inhibits farnesyl pyrophosphate analogs protein transferase | 26.177613259668 | ||
| 10007602 |
Δ2- |
93772-82-8 | ≥98% |
|
2006-01-04 | 0E-12 | -2-cis-eicosenoic-acid | .alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-trans D2 extracted fresh wateer clams medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats | 0E-12 | |||
| 10007622 |
Δ2- |
- | ≥98% |
|
2006-01-04 | 0E-12 | -2-trans-eicosenoic-acid | .alpha.,.beta.-unsaturated fatty acids a,b-unsaturated synthesis .DELTA.2-cis D2 medical medicinal diabetes lipids metabolisms 2-octadecenoic livers blood sugars streptozocin-induced rats | 0E-12 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search